This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
Three interventions were considered: the LNG-IUS, the combined oral contraceptive, and progestogens. Patients could switch from one treatment to another if treatment failed. A surgical procedure (hysterectomy or resection) could be undertaken in the case of repeated failure.
Location/setting
Spain/hospital and secondary care.
Methods

Analytical approach:
The analysis was based on a Markov model, with a hypothetical cohort of women with a previous diagnosis of idiopathic heavy menstrual bleeding. Two scenarios were considered: a contraception scenario, where patients do not wish to have children and contraception was included, and a dysfunctional uterine bleeding scenario, which focused on the control of bleeding only. A five-year time horizon was considered. The authors stated that the analysis was conducted from the perspective of the Spanish National Health System.
Effectiveness data:
The clinical sources of evidence were identified by a review of the literature in commonly used electronic databases. These inputs were validated by Spanish clinical experts. The key model input was the treatment success, which was defined as the proportion of patients responding to treatment and not becoming pregnant.
Monetary benefit and utility valuations:
The utility values were from published studies that used the European Quality of life (EQ-5D) scale. UK tariffs were used, as there were no Spanish values.
Measure of benefit:
Three benefit measures were considered: symptom-free months, surgery-free months, and quality-adjusted life-months (QALMs). A 3% annual discount rate was applied.
